학술논문
Dupilumab improves long-term outcomes in patients with uncontrolled, moderate-to-severe GINA-based type 2 asthma, irrespective of allergic status
Document Type
Article
Author
Source
In: Allergy: European Journal of Allergy and Clinical Immunology . (Allergy: European Journal of Allergy and Clinical Immunology, August 2023, 78(8):2148-2156)
Subject
Language
English
ISSN
13989995
01054538
01054538